Tyrosine Kinase Inhibitors Influence ABCG2 Expression in EGFR-Positive MDCK BCRP Cells via the PI3K/Akt Signaling Pathway
Version of Record online: 22 FEB 2012
Copyright © 2012 WILEY-VCH Verlag GmbH & Co. KGaA, Weinheim
Volume 7, Issue 4, pages 650–662, April 2012
How to Cite
Pick, A. and Wiese, M. (2012), Tyrosine Kinase Inhibitors Influence ABCG2 Expression in EGFR-Positive MDCK BCRP Cells via the PI3K/Akt Signaling Pathway. ChemMedChem, 7: 650–662. doi: 10.1002/cmdc.201100543
- Issue online: 27 MAR 2012
- Version of Record online: 22 FEB 2012
- Manuscript Revised: 17 JAN 2012
- Manuscript Received: 22 NOV 2011
Detailed facts of importance to specialist readers are published as ”Supporting Information”. Such documents are peer-reviewed, but not copy-edited or typeset. They are made available as submitted by the authors.
Please note: Wiley Blackwell is not responsible for the content or functionality of any supporting information supplied by the authors. Any queries (other than missing content) should be directed to the corresponding author for the article.